Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients

被引:176
作者
Chen, Xi [1 ]
Wan, Jin [2 ]
Liu, Jiankun [1 ]
Xie, Wei [1 ]
Diao, Xinwei [3 ]
Xu, Jianping [3 ]
Zhu, Bo [1 ]
Chen, Zhengtang [1 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing 400037, Peoples R China
[2] Chongqing Inst Technol, Coll Chem & Bioengn, Chongqing 400050, Peoples R China
[3] Xinqiao Hosp, Dept Pathol, Chongqing 400037, Peoples R China
关键词
IL-17; Th17; Non-small cell lung carcinoma; Lymphangiogenesis; HUMAN INTERLEUKIN-17 GENE; SENTINEL LYMPH-NODES; GROWTH-FACTOR-C; LUNG-CANCER; T-CELLS; OVARIAN-CANCER; TUMOR-GROWTH; IL-17; METASTASIS; EXPRESSION;
D O I
10.1016/j.lungcan.2009.11.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The presence of IL-17-positive cells is observed in a variety of inflammatory associated cancers and IL-17 has been found to be involved in angiogenesis. The aim of this study is to determine the prognostic significance of IL-17 in NSCLC patients and to examine the correlation between IL-17 expression and lymphatic vessel density in NSCLC tissues. The expression of IL-17 was measured by immunohistochemistry in 52 paraffin-embedded tissues with non-small cell lung cancer. The chi(2) test was used to analyze the correlation between IL-17 expression and clinical parameters and lymphatic vessel density (LVD). The Kaplan-Meier method, univariate and multivariate regression analysis was used to analyze the correlation between IL-17 expression and overall survival and disease-free survival. High expression of IL-17 was observed in 25 of 52 lung cancer patients and was associated with smoking status, TNM stage, LVD, overall survival and disease-free survival. Univariate and multivariate analysis showed that IL-17 was an independent prognostic factor for overall survival and disease-free survival. Our results indicate that IL-17 may play a role in the metastasis of lung cancer by promoting lymphangiogenesis. IL-17 expression is an independent prognostic factor in both overall and disease-free survival in NSCLC. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:348 / 354
页数:7
相关论文
共 42 条
[1]   Tumor lymphangiogenesis and metastatic spread - New players begin to emerge [J].
Achen, Marc G. ;
Stacker, Steven A. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (08) :1755-1760
[2]   Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism [J].
Benchetrit, F ;
Ciree, A ;
Vives, V ;
Warnier, G ;
Gey, A ;
Sautès-Fridman, C ;
Fossiez, F ;
Haicheur, N ;
Fridman, WH ;
Tartour, E .
BLOOD, 2002, 99 (06) :2114-2121
[3]   Prognostic factors in non-small cell lung cancer - A decade of progress [J].
Brundage, MD ;
Davies, D ;
Mackillop, WJ .
CHEST, 2002, 122 (03) :1037-1057
[4]   Tumor-derived lymphangiogenic factors and lymphatic metastasis [J].
Cao, Yihai ;
Zhong, Weide .
BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (09) :534-539
[5]  
Cha HS, 2007, J RHEUMATOL, V34, P16
[6]   Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer [J].
Chen, FS ;
Takenaka, K ;
Ogawa, E ;
Yanagihara, K ;
Otake, Y ;
Wada, H ;
Tanaka, F .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8548-8553
[7]   TH 17 cells in development:: an updated view of their molecular identity and genetic programming [J].
Dong, Chen .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (05) :337-348
[8]   Increased expression of interleukin 17 in inflammatory bowel disease [J].
Fujino, S ;
Andoh, A ;
Bamba, S ;
Ogawa, A ;
Hata, K ;
Araki, Y ;
Bamba, T ;
Fujiyama, Y .
GUT, 2003, 52 (01) :65-70
[9]   An overview of IL-17 function and signaling [J].
Gaffen, Sarah L. .
CYTOKINE, 2008, 43 (03) :402-407
[10]   Type 17 CD8+ T cells display enhanced antitumor immunity [J].
Hinrichs, Christian S. ;
Kaiser, Andrew ;
Paulos, Chrystal M. ;
Cassard, Lydie ;
Sanchez-Perez, Luis ;
Heemskerk, Bianca ;
Wrzesinski, Claudia ;
Borman, Zachary A. ;
Muranski, Pawel ;
Restifo, Nicholas P. .
BLOOD, 2009, 114 (03) :596-599